VXRT - Vaxart: A Retail Shareholder's Perspective
Introduction
Vaxart (VXRT) is a small cap, clinical-stage biotech company, based in South San Francisco, Calif., that develops oral vaccines, which the company believes represent "an important advancement in vaccination technology".
I have previously written a SA article on VXRT, if interested.
On June 26, Vaxart announced that "its oral COVID-19 vaccine has been selected to participate in a non-human primate (NHP) challenge study, organized and funded by Operation Warp Speed".
The news was well received and the stock closed up 28% ($6.26 to $8.04) from the previous day close.
Similar to